Literature DB >> 20454890

Measuring anxiety- and locomotion-related behaviours in mice: a new way of using old tests.

Leanne M Fraser1, Richard E Brown, Ahmed Hussin, Mara Fontana, Ashley Whittaker, Timothy P O'Leary, Lauren Lederle, Andrew Holmes, André Ramos.   

Abstract

RATIONALE: Batteries of tests that are thought to measure different aspects of anxiety-related behaviour are used to characterise mice after genetic or pharmacological manipulation. However, because of the potentially confounding effects of repeated testing and natural intra-individual variations in behaviour over time, subjecting mice to a succession of tests is not ideal.
OBJECTIVES: The aim of this study was to investigate, in mice, the utility of an integrated apparatus that combines three classical tests of anxiety, the open field, elevated plus maze (EPM) and light/dark box.
METHODS: Mice from four different strains (CD-1, BALB/cJ, DBA/2J, C57BL/6J) were used in a series of five experiments where their behaviour was observed for 15 min in the integrated apparatus. Responses to anxiety-modulating drugs and 2-day repeated testing were evaluated.
RESULTS: CD-1 mice explored the apparatus thoroughly, providing measures from all areas throughout the entire testing session. Factor analysis showed that measures of locomotion and anxiety-related behaviour were dissociable. BALB/cJ, DBA/2J and C57BL/6J showed markedly different behavioural profiles, largely consistent with previous studies examining individual tests. Avoidance of aversive environments did not increase with repeated testing. In CD-1 mice, the anxiolytics diazepam and alprazolam (4 and 2 mg/kg, respectively) increased the approach towards the EPM open arms. Alprazolam also had sedative effects, whereas the anxiogenic pentylenetetrazole had no effects.
CONCLUSIONS: These findings suggest that the triple test is sensitive to genetic/pharmacological influences on anxiety and locomotion and that, by providing quasi-simultaneous measures from three different apparatuses, it may represent an alternative to the use of test batteries.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20454890     DOI: 10.1007/s00213-010-1873-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  58 in total

1.  The use of behavioral test batteries, II: effect of test interval.

Authors:  Richard Paylor; Corinne M Spencer; Lisa A Yuva-Paylor; Sandra Pieke-Dahl
Journal:  Physiol Behav       Date:  2005-09-28

2.  Strain differences in response to a benzodiazepine receptor inverse agonist (FG 7142) in mice.

Authors:  D J Nutt; R G Lister
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Animal models for the study of anti-anxiety agents: a review.

Authors:  D Treit
Journal:  Neurosci Biobehav Rev       Date:  1985       Impact factor: 8.989

4.  Common variations in the pretest environment influence genotypic comparisons in models of anxiety.

Authors:  G S Izídio; D M Lopes; L Spricigo; A Ramos
Journal:  Genes Brain Behav       Date:  2005-10       Impact factor: 3.449

5.  Differences among nine 1,4-benzodiazepines: an ethopharmacological evaluation in mice.

Authors:  A Sulcova; M Krsiak
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 6.  Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies.

Authors:  J N Crawley; J K Belknap; A Collins; J C Crabbe; W Frankel; N Henderson; R J Hitzemann; S C Maxson; L L Miner; A J Silva; J M Wehner; A Wynshaw-Boris; R Paylor
Journal:  Psychopharmacology (Berl)       Date:  1997-07       Impact factor: 4.530

7.  "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?

Authors:  S E File; H Zangrossi
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 8.  Pharmacology of the beta-carboline FG-7,142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects.

Authors:  Andrew K Evans; Christopher A Lowry
Journal:  CNS Drug Rev       Date:  2007

9.  Genetic relationship between anxiety-related and fear-related behaviors in BXD recombinant inbred mice.

Authors:  Jonathan L Brigman; Poonam Mathur; Lu Lu; Robert W Williams; Andrew Holmes
Journal:  Behav Pharmacol       Date:  2009-03       Impact factor: 2.293

Review 10.  Animal models of behavioral dysfunctions: basic concepts and classifications, and an evaluation strategy.

Authors:  F Josef van der Staay
Journal:  Brain Res Rev       Date:  2006-03-10
View more
  25 in total

1.  The influence of sex and estrous cycle on QTL for emotionality and ethanol consumption.

Authors:  Geison S Izídio; Letícia C Oliveira; Lígia F G Oliveira; Elayne Pereira; Thaize D Wehrmeister; André Ramos
Journal:  Mamm Genome       Date:  2011-04-24       Impact factor: 2.957

2.  Insulin reverses anxiety-like behavior evoked by streptozotocin-induced diabetes in mice.

Authors:  Deepali Gupta; Mahesh Radhakrishnan; Yeshwant Kurhe
Journal:  Metab Brain Dis       Date:  2014-04-25       Impact factor: 3.584

3.  Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and sex.

Authors:  Jean-Philippe Guilloux; Marianne Seney; Nicole Edgar; Etienne Sibille
Journal:  J Neurosci Methods       Date:  2011-01-26       Impact factor: 2.390

4.  Role of prefrontal 5-HT in the strain-dependent variation in sign-tracking behavior of C57BL/6 and DBA/2 mice.

Authors:  P Campus; A Accoto; M Maiolati; C Latagliata; C Orsini
Journal:  Psychopharmacology (Berl)       Date:  2016-01-04       Impact factor: 4.530

5.  Perinatal vs genetic programming of serotonin states associated with anxiety.

Authors:  Stefanie C Altieri; Hongyan Yang; Hannah J O'Brien; Hannah M Redwine; Damla Senturk; Julie G Hensler; Anne M Andrews
Journal:  Neuropsychopharmacology       Date:  2014-12-19       Impact factor: 7.853

6.  Bidirectional Control of Anxiety-Related Behaviors in Mice: Role of Inputs Arising from the Ventral Hippocampus to the Lateral Septum and Medial Prefrontal Cortex.

Authors:  Gustavo Morrone Parfitt; Robin Nguyen; Jee Yoon Bang; Afif J Aqrabawi; Matthew M Tran; D Kanghoon Seo; Blake A Richards; Jun Chul Kim
Journal:  Neuropsychopharmacology       Date:  2017-03-15       Impact factor: 7.853

7.  Anxiolytic properties of new chemical entity, 5TIO1.

Authors:  Amanda C Fortes; Antonia Amanda C Almeida; Francisco Jaime B Mendonça-Júnior; Rivelilson M Freitas; José Lamartine Soares-Sobrinho; Monica Felts de La Roca Soares
Journal:  Neurochem Res       Date:  2013-01-19       Impact factor: 3.996

8.  Repetitive grooming and sensorimotor abnormalities in an ephrin-A knockout model for Autism Spectrum Disorders.

Authors:  Rachel Wurzman; Patrick A Forcelli; Christopher J Griffey; Lawrence F Kromer
Journal:  Behav Brain Res       Date:  2014-10-02       Impact factor: 3.332

9.  Use of the light/dark test for anxiety in adult and adolescent male rats.

Authors:  Andrew E Arrant; Nicole L Schramm-Sapyta; Cynthia M Kuhn
Journal:  Behav Brain Res       Date:  2013-05-27       Impact factor: 3.332

10.  Melanopsin-expressing retinal ganglion cell loss and behavioral analysis in the Thy1-CFP-DBA/2J mouse model of glaucoma.

Authors:  Qi Zhang; Helen Vuong; Xin Huang; YanLing Wang; Nicholas C Brecha; MingLiang Pu; Jie Gao
Journal:  Sci China Life Sci       Date:  2013-06-01       Impact factor: 6.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.